KLK3 and cancer: The latter may have been particularly impactful as this group may have more heterogeneous protein expression and overlapping, confounding signal between prostate abnormality and cancer compared to healthy, age-matched men without elevated PSA, a less relevant comparator class for our clinical endpoint.